Annual CFF
$44.16 M
-$142.08 M-76.29%
December 31, 2024
Summary
- As of February 25, 2025, WGS annual cash flow from financing activities is $44.16 million, with the most recent change of -$142.08 million (-76.29%) on December 31, 2024.
- During the last 3 years, WGS annual CFF has fallen by -$449.57 million (-91.06%).
- WGS annual CFF is now -91.06% below its all-time high of $493.73 million, reached on December 31, 2021.
Performance
WGS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$31.02 M
+$17.05 M+122.10%
December 31, 2024
Summary
- As of February 25, 2025, WGS quarterly cash flow from financing activities is $31.02 million, with the most recent change of +$17.05 million (+122.10%) on December 31, 2024.
- Over the past year, WGS quarterly CFF has dropped by -$16.08 million (-34.14%).
- WGS quarterly CFF is now -93.79% below its all-time high of $499.40 million, reached on September 1, 2021.
Performance
WGS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$44.16 M
-$16.08 M-26.69%
December 31, 2024
Summary
- As of February 25, 2025, WGS TTM cash flow from financing activities is $44.16 million, with the most recent change of -$16.08 million (-26.69%) on December 31, 2024.
- Over the past year, WGS TTM CFF has dropped by -$142.08 million (-76.29%).
- WGS TTM CFF is now -93.66% below its all-time high of $696.27 million, reached on June 1, 2022.
Performance
WGS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WGS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.3% | -34.1% | -76.3% |
| 3 y3 years | -91.1% | -34.1% | -76.3% |
| 5 y5 years | -70.2% | -34.1% | -76.3% |
WGS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.1% | at low | -84.3% | +3114.9% | -93.7% | at low |
| 5 y | 5-year | -91.1% | at low | -93.8% | +1409.5% | -93.7% | +1050.3% |
| alltime | all time | -91.1% | at low | -93.8% | +1409.5% | -93.7% | +1050.3% |
GeneDx Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $44.16 M(-76.3%) | $31.02 M(+122.1%) | $44.16 M(-26.7%) |
| Sep 2024 | - | $13.97 M(-3672.4%) | $60.24 M(+32.8%) |
| Jun 2024 | - | -$391.00 K(-10.7%) | $45.36 M(-14.6%) |
| Mar 2024 | - | -$438.00 K(-100.9%) | $53.14 M(-71.5%) |
| Dec 2023 | $186.24 M(-5.6%) | $47.10 M(-5270.5%) | $186.24 M(+33.8%) |
| Sep 2023 | - | -$911.00 K(-112.3%) | $139.20 M(-0.2%) |
| Jun 2023 | - | $7.39 M(-94.4%) | $139.46 M(-57.8%) |
| Mar 2023 | - | $132.66 M(>+9900.0%) | $330.13 M(+67.3%) |
| Dec 2022 | $197.31 M | $65.00 K(-110.0%) | $197.31 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$647.00 K(-100.3%) | $196.22 M(-71.8%) |
| Jun 2022 | - | $198.06 M(<-9900.0%) | $696.27 M(+40.4%) |
| Mar 2022 | - | -$160.00 K(-84.5%) | $495.85 M(+0.4%) |
| Dec 2021 | $493.73 M(+282.6%) | - | - |
| Dec 2021 | - | -$1.03 M(-100.2%) | $493.73 M(-0.2%) |
| Sep 2021 | - | $499.40 M(<-9900.0%) | $494.76 M(<-9900.0%) |
| Jun 2021 | - | -$2.37 M(+4.0%) | -$4.65 M(+104.0%) |
| Mar 2021 | - | -$2.28 M | -$2.28 M |
| Dec 2020 | $129.06 M(-12.8%) | - | - |
| Dec 2019 | $148.01 M | - | - |
FAQ
- What is GeneDx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GeneDx Holdings?
- What is GeneDx Holdings annual CFF year-on-year change?
- What is GeneDx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GeneDx Holdings?
- What is GeneDx Holdings quarterly CFF year-on-year change?
- What is GeneDx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GeneDx Holdings?
- What is GeneDx Holdings TTM CFF year-on-year change?
What is GeneDx Holdings annual cash flow from financing activities?
The current annual CFF of WGS is $44.16 M
What is the all time high annual CFF for GeneDx Holdings?
GeneDx Holdings all-time high annual cash flow from financing activities is $493.73 M
What is GeneDx Holdings annual CFF year-on-year change?
Over the past year, WGS annual cash flow from financing activities has changed by -$142.08 M (-76.29%)
What is GeneDx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of WGS is $31.02 M
What is the all time high quarterly CFF for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash flow from financing activities is $499.40 M
What is GeneDx Holdings quarterly CFF year-on-year change?
Over the past year, WGS quarterly cash flow from financing activities has changed by -$16.08 M (-34.14%)
What is GeneDx Holdings TTM cash flow from financing activities?
The current TTM CFF of WGS is $44.16 M
What is the all time high TTM CFF for GeneDx Holdings?
GeneDx Holdings all-time high TTM cash flow from financing activities is $696.27 M
What is GeneDx Holdings TTM CFF year-on-year change?
Over the past year, WGS TTM cash flow from financing activities has changed by -$142.08 M (-76.29%)